Taken together, the phenotypic and molecular analyses of transgenic and nontransgenic B cells uncovered cancer-relevant biological consequences of XBP-1s overexpression, including B cell hyperproliferation and IL-6 activation, both of which are plausible mechanisms capable of driving plasma-cell transformation. The gene discussed is IL6; the disease is cancer.